Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.75
+0.19 (2.90%)
At close: May 12, 2025, 4:00 PM
6.77
+0.02 (0.30%)
After-hours: May 12, 2025, 5:42 PM EDT

Sage Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-354.4-400.67-541.49-532.78-457.89606.07
Upgrade
Depreciation & Amortization
0.811.031.391.124.182.63
Upgrade
Loss (Gain) From Sale of Investments
-6.37-6.83-6.474.35-10.6-0.69
Upgrade
Stock-Based Compensation
47.7354.573.3761.6104.6395.99
Upgrade
Change in Accounts Payable
-1.042.38-8.58.436.69-11.51
Upgrade
Change in Other Net Operating Assets
2.1882.38-58.89-2.76-25.2-28.22
Upgrade
Operating Cash Flow
-311.09-267.19-540.59-460.04-378.18664.28
Upgrade
Capital Expenditures
---0.55-0.94-0.37-0.35
Upgrade
Investment in Securities
173.03266.68443.47326.37-1,002443.03
Upgrade
Investing Cash Flow
173.03266.68442.91325.43-1,002442.68
Upgrade
Issuance of Common Stock
9.8711.186.933.1114.72426.76
Upgrade
Repurchase of Common Stock
-0.5-0.4-0.9-0.04-1.39-
Upgrade
Other Financing Activities
-0.12-0.12----
Upgrade
Financing Cash Flow
9.2510.666.033.0713.33426.76
Upgrade
Net Cash Flow
-128.8110.15-91.65-131.53-1,3671,534
Upgrade
Free Cash Flow
-311.09-267.19-541.14-460.97-378.55663.94
Upgrade
Free Cash Flow Margin
-656.25%-647.85%-625.92%-5997.57%-6001.17%59.59%
Upgrade
Free Cash Flow Per Share
-5.08-4.40-9.04-7.77-6.4512.53
Upgrade
Levered Free Cash Flow
-179.04-119.04-333.05-272.33-195.97448.8
Upgrade
Unlevered Free Cash Flow
-179.04-119.04-333.05-272.33-195.97448.8
Upgrade
Change in Net Working Capital
2.72-8265.71-7.7516.3439.46
Upgrade
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q